APO-go
APO-go is an originator product from Spirig HealthCare AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 168.20 to CHF 178.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Spirig HealthCare AG
- ATC code
- N04BC07
- IT group
- 01.08 Parkinson
- Active substances
- Apomorphini hydrochloridum hemihydricum
- Preparation type
- Originator product
- On the SL since
- 01/02/2020
- Last price change
- 01/01/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 30 mg/3 ml Pen | 3 ml 5 Stk | CHF 139.55 | CHF 168.20 | 01/02/2023 | B | 7680631750050 |
| Inf Lös 100 mg/20ml Patrone | 5 Patronen 20 ml | CHF 149.45 | CHF 178.95 | 01/01/2024 | B | 7680686040014 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Die Patienten müssen in der Lage sein, den Beginn ihrer Off-Symptome selber zu erkennen und die Selbstverabreichung mit dem Pen vorzunehmen bzw. eine Betreuungsperson zur Verfügung haben, die dazu in der Lage ist.
Die Verordnung und die Überwachung der Therapie darf ausschliesslich durch einen in der Behandlung der Parkinson'schen Krankheit erfahrenen Facharzt der Neurologie erfolgen.
Die Verordnung und die stationäre Einstellung darf ausschliesslich durch eine auf die Behandlung der Parkinson’schen Krankheit spezialisierte, durch das BAG definierte Klinik erfolgen (vgl. Liste publiziert unter http://www.bag.admin.ch/sl-ref).
Die Überwachung der Therapie darf ausschliesslich durch einen in der Behandlung der Parkinson'schen Krankheit erfahrenen Facharzt der Neurologie erfolgen.
More preparations in this group
FAQ
Is APO-go covered by Swiss health insurance?
Yes, but only under conditions. APO-go is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does APO-go cost in Switzerland?
The public price is the maximum price set by the FOPH and for APO-go ranges from CHF 168.20 to CHF 178.95 per pack. The ex-factory price ranges from CHF 139.55 to CHF 149.45. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages